Montreal prognostic score: Estimating survival of patients with non-small cell lung cancer using clinical biomarkers

British Journal of Cancer

Volumn 109, Issue 8, 2013, Pages 2066-2071

  Gagnon, B ^a   Agulnik, J S ^b   Gioulbasanis, I ^c   Kasymjanova, G ^b   Morris, D ^d   Macdonald, N ^e  

^a LAVAL UNIVERSITY   (Canada)

^b MCGILL UNIVERSITY   (Canada)

^c UNIVERSITY HOSPITAL OF LARISSA   (Greece)

^d MCGILL UNIVERSITY   (Canada)

^e Bronfman Jewish Educational Center   (Canada)

Author keywords

C reactive protein; lactate dehydrogenase; lung cancer; prognostic; survival

Indexed keywords

ALBUMIN; ANTINEOPLASTIC AGENT; BIOLOGICAL MARKER; C REACTIVE PROTEIN; LACTATE DEHYDROGENASE;

AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER PROGNOSIS; CANCER STAGING; CANCER SURVIVAL; FEMALE; HUMAN; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; MONTREAL PROGNOSTIC SCORE; PRIORITY JOURNAL; QUALITY OF LIFE; SCORING SYSTEM;

AGED; CARCINOMA, NON-SMALL-CELL LUNG; COHORT STUDIES; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; LUNG NEOPLASMS; MALE; MIDDLE AGED; PROGNOSIS; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL;

EID: 84885907262     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/bjc.2013.515     Document Type: Article

References (28)

1. Al-Shaiba R, McMillan DC, Angerson WJ, Leen E, McArdle CS, Horgan P (2004) The relationship between hypoalbuminaemia, tumour volume and the systemic inflammatory response in patients with colorectal liver metastases. Br J Cancer 91(2): 205-207.
2. Arkenau HT, Olmos D, Ang JE, de BJ, Judson I, Kaye S (2008) Clinical outcome and prognostic factors for patients treated within the context of a phase I study: The Royal Marsden Hospital experience. Br J Cancer 98(6): 1029-1033.
3. Breiman L, Friedman J, Olshen R, Stone C (1984) Classification and Regression Trees. Wadsworth International Group: Belmont, CA.
4. Chow E, Abdolell M, Panzarella T, Harris KE, Bezjak A, Warde P, Tannock I (2008) Predictive model for survival in patients with advanced cancer. J Clin Oncol 26(36): 5863-5869.
5. Chua W, Charles KA, Baracos VE, Clarke SJ (2011) Neutrophil/lymphocyte ratio predicts chemotherapy outcomes in patients with advanced colorectal cancer. Br J Cancer 104(8): 1288-1295.
6. Faraggi D, LeBlanc M, Crowley JJ (2001) Understanding neural networks using regression trees: An application to multiple myeloma survival data. Stat Med 20(19): 2965-2976.
7. Gagnon B, Abrahamowicz M, Xiao Y, Beauchamp ME, MacDonald N, Kasymjanova G, Kreisman H, Small D (2010) Flexible modeling improves assessment of prognostic value of C-reactive protein in advanced non-small cell lung cancer. Br J Cancer 102(7): 1113-1122.
8. Gioulbasanis I, Pallis A, Vlachostergios PJ, Xyrafas A, Giannousi Z, Perdikouri IE, Makridou M, Kakalou D, Georgoulias V (2012) The Glasgow Prognostic Score (GPS) predicts toxicity and efficacy in platinum-based treated patients with metastatic lung cancer. Lung Cancer 77(2): 383-388.
9. Grambsh PM, Therneau TM (1994) Proportional hazards tests and diagnostics based on weighted residuals. Biometrika 81: 515-526.
10. Guthrie GJK, Roxburgh CSD, Farhan-Alanie OM, Horgan PG, McMillan DC (2013) Comparison of the prognostic value of longitudinal measurements of systemic inflammation in patients undergoing curative resection of colorectal cancer. Br J Cancer 109(1): 24-28.
11. Harrell Jr FE, Califf RM, Pryor DB, Lee KL, Rosati RA (1982) Evaluating the yield of medical tests. JAMA 247(18): 2543-2546.
12. Harrell Jr FE, Lee KL, Mark DB (1996) Multivariable prognostic models: Issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat Med 15(4): 361-387.
13. Kasymjanova G, MacDonald N, Agulnik JS, Cohen V, Pepe C, Kreisman H, Sharma R, Small D (2010) The predictive value of pre-treatment inflammatory markers in advanced non-small-cell lung cancer. Curr Oncol 17(4): 52-58.
14. Koukourakis MI, Giatromanolaki A, Simopoulos C, Polychronidis A, Sivridis E (2005) Lactate dehydrogenase 5 (LDH5) relates to up-regulated hypoxia inducible factor pathway and metastasis in colorectal cancer. Clin Exp Metastasis 22(1): 25-30.
15. Koukourakis MI, Giatromanolaki A, Sivridis E, Bougioukas G, Didilis V, Gatter KC, Harris AL (2003) Lactate dehydrogenase-5 (LDH-5) overexpression in non-small-cell lung cancer tissues is linked to tumour hypoxia, angiogenic factor production and poor prognosis. Br J Cancer 89(5): 877-885.
16. Leung EY, Scott HR, McMillan DC (2012) Clinical utility of the pretreatment glasgow prognostic score in patients with advanced inoperable non-small cell lung cancer. J Thorac Oncol 7(4): 655-662.
17. Liu Y, Fuchs J, Li C, Lin J (2010) IL-6, a risk factor for hepatocellular carcinoma: FLLL32 inhibits IL-6-induced STAT3 phosphorylation in human hepatocellular cancer cells. Cell Cycle 9(17): 3423-3427.
18. McMillan DC (2009) Systemic inflammation, nutritional status and survival in patients with cancer. Curr Opin Clin Nutr Metab Care 12(3): 223-226.
19. Nixon DW, Heymsfield SB, Cohen AE, Kutner MH, Ansley J, Lawson DH, Rudman D (1980) Protein-calorie undernutrition in hospitalized cancer patients. Am J Med 68(5): 683-690.
20. Osta BE, Palmer JL, Paraskevopoulos T, Pei BL, Roberts LE, Poulter VA, Chacko R, Bruera E (2008) Interval between first palliative care consult and death in patients diagnosed with advanced cancer at a comprehensive cancer center. J Palliative Med 11(1): 51-57.
21. Pencina MJ, D?Agostino RB (2004) Overall C as a measure of discrimination in survival analysis: Model specific population value and confidence interval estimation. Stat Med 23(13): 2109-2123.
22. Proctor MJ, Morrison DS, Talwar D, Balmer SM, Fletcher CD, O?Reilly DS, Foulis AK, Horgan PG, McMillan DC (2011) A comparison of inflammation-based prognostic scores in patients with cancer. A Glasgow Inflammation Outcome Study. Eur J Cancer 47(17): 2633-2641.
23. Semenza GL (2011) Oxygen sensing, homeostasis, and disease. N Engl J Med 365(6): 537-547.
24. Smith TJ, Temin S, Alesi ER, Abernethy AP, Balboni TA, Basch EM, Ferrell BR, Loscalzo M, Meier DE, Paice JA, Peppercorn JM, Somerfield M, Stovall E, Von Roenn JH (2012) American Society of Clinical Oncology provisional clinical opinion: The integration of palliative care into standard oncology care. J Clin Oncol 30(8): 880-887.
25. Temel JS, Greer JA, Muzikansky A, Gallagher ER, Admane S, Jackson VA, Dahlin CM, Blinderman CD, Jacobsen J, Pirl WF, Billings JA, Lynch TJ (2010) Early palliative care for patients with metastatic non-small-cell lung cancer. N Engl J Med 363(8): 733-742.
26. Therneau TM, Atkinson EJ (1997) An introduction to recursive partitioning using the rpart routines 61, Mayo Clinic, Rochester, Department of Health Science Research.
27. Warburg O (1956) On the origin of cancer cells. Science 123(3191): 309-314.
28. Yamanaka T, Matsumoto S, Teramukai S, Ishiwata R, Nagai Y, Fukushima M (2008) The baseline ratio of neutrophils to lymphocytes is associated with patient prognosis in advanced gastric cancer. Oncology 73(3-4): 215-220